34,538,185 and 26,788,986 shares
issued and outstanding 35 27
Treasury stock, 433,333 shares, at cost (433) (433)
Additional paid-in capital 275,782 241,389
Accumulated other comprehensive income 124 14
Accumulated deficit (242,417) (221,524)
---------- ---------
Total Shareholders' Equity 33,091 19,473
---------- ---------
TOTAL LIABILITIES AND SHAREHOLDERS'
EQUITY $ 40,270 $ 27,893
========== =========
The accompanying notes are an integral part of these
condensed financial statements.
Genelux Corporation
Condensed Statements of Operations
(in thousands, except for share amounts and per share
data)
Three Months Ended Nine Months Ended
September 30, September 30,
-------------------------- ----------------------------
2024 2023 2024 2023
(Unaudited) (Unaudited)
Revenues $ - $ - $ 8 $ 170
---------- ---------- ---------- ----------
Operating
expenses:
Research and
development 4,051 2,819 12,478 8,607
General and
administrative 2,890 2,488 9,478 8,727
---------- ---------- ---------- ----------
Total operating
expenses 6,941 5,307 21,956 17,334
---------- ---------- ---------- ----------
Loss from
operations (6,941) (5,307) (21,948) (17,164)
---------- ---------- ---------- ----------
Other income
(expenses):
Interest income 474 4 1,055 4
Interest
expense - - - (167)
Debt discount
amortization - - - (649)
Financing costs - (42) - (3,152)
Debt
extinguishment
costs - (402)
Total other
income
(expenses), net 474 (38) 1,055 (4,366)
---------- ---------- ---------- ----------
NET LOSS $ (6,467) $ (5,345) $ (20,893) $ (21,530)
========== ========== ========== ==========
LOSS PER COMMON
SHARE - BASIC
AND DILUTED $ (0.19) $ (0.20) $ (0.69) $ (0.91)
========== ========== ========== ==========
WEIGHTED-AVERAGE
COMMON SHARES
OUTSTANDING -
BASIC AND
DILUTED 34,532,355 26,210,068 30,405,615 23,640,995
========== ========== ========== ==========
The accompanying notes are an integral part of these
condensed financial statements.
Genelux Corporation
Condensed Statements of Comprehensive Loss
(in thousands)
Three Months Ended Nine Months Ended
September 30, September 30,
------------------ ----------------------
2024 2023 2024 2023
(Unaudited) (Unaudited)
Net loss $(6,467) $(5,345) $(20,893) $(21,530)
Other
comprehensive
loss:
Net unrealized
gain on short
and long-term
investments 135 - 110 -
Comprehensive
loss $(6,332) $(5,345) $(20,783) $(21,530)
====== ====== ======= =======
The accompanying notes are an integral part of these
condensed financial statements.
(END) Dow Jones Newswires
November 14, 2024 16:05 ET (21:05 GMT)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。